Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Many gynecological cancer patients face barriers to treatment and support. This Westchester woman helped uncover the gaps and seek solutions.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Lawyers claim Johnson & Johnson knew that the product contained cancer causing asbestos, but failed to warn customers and continued to sell it until 2022.

Lawyers representing 3,500 claimants are preparing to sue Johnson & Johnson (J&J) over alleged links between its talcum ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

Johnson & Johnson (JNJ) faces a $1B+ reimbursement demand for cancer cases linked to talc products. Read more here.

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal ...